MedTrace Logo

Is Levocetirizine Less Sedating Than Cetirizine?

NCT00826943 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2014-02-20

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to determine whether cetirizine (zyrtec), levocetirizine (xyzal), and placebo differ in the degree of sedation they produce and their relief of allergy symptoms.

Conditions

  • Allergic Rhinitis

Interventions

DRUG

Cetirizine

Cetirizine 10 mg tab daily x 7 days

DRUG

Levocetirizine

5 mg tab daily x 7 days

DRUG

Placebo

Placebo tablet daily x 7 days

Sponsors & Collaborators

  • Vanderbilt University

    lead OTHER

Principal Investigators

  • Douglas B Tzanetos, M.D. · Vanderbilt University Medical Center

  • John M Fahrenholz, M.D. · Vanderbilt University Medical Center

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
77 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-01-31
Primary Completion
2009-05-31
Completion
2009-05-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00826943 on ClinicalTrials.gov